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Background: The immunosuppresion in HIV patients makes them highly susceptible to microbial infections. The
aim of the study was to establish whether HIV stage (as depicted by CD4+ T lymphocyte counts) could
independently be associated with periodontal status (as revealed by the measurement of clinical indices).
Methods: One hundred and twenty HIV-infected patients attending an infectious diseases clinic in the Western Cape,
South Africa were included in the study. The periodontal clinical indices such as plaque index, gingival index, pocket
probing depth and clinical attachment levels were measured on the mesial aspect of the six Ramfjord teeth. The
CD4 + T cell counts were taken from the patients’ medical records and patients’ HIV stage determined and grouped
according to their CD4+ T cell counts into A (<200 cells /mm3), B (200–500 cells /mm3) and C (>500 cells /mm3).
Results: The mean age of 120 HIV-positive patients was 33.25 years and the mean CD4 + T cell count was
293.43 cells/mm3. The probing depth and clinical attachment loss were found to be significantly associated with
the total CD4 + T cell counts but not with HIV stage. Significant correlations were found between age and all
clinical indices except for clinical attachment loss. No correlation was found between age and HIV stage of the
patients. The use of antiretroviral therapy was significantly associated with probing depth and clinical attachment
loss, but not with plaque nor gingival index. Significant associations were observed between smoking and all of
the clinical indices except for the gingival index. A significant association was observed between the use of
interdental aids and all the clinical indices except for probing depth, while brushing was significantly associated
with plaque index only. CD4 + T cell counts were significantly associated with brushing frequency (p = 0.0190)
and the use of interdental aids (p = 0.0170).
Conclusion: The findings of this study conclude that HIV stage, ART and age are not independent risk factors for
changes in the periodontal status of HIV-positive subjects but rather that smoking and oral hygiene habits
determine their susceptibility to disease.
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Table 1 Mean (SD) and median of age, periodontal
indices and CD4 + T cell counts
Variables n Mean (SD) Median Minimum-
Maximum
Age (years) 120 33.25 (7.42) 32 20-55
Plaque index 120 2.55 (0.54) 2.8 0.8-3
Gingival index 120 2.75 (0.45) 3 0.5-3
Probing depth 120 4.77 (1.04) 4.9 2.9-6.8
Clinical attachment
loss
120 5.29 (1.1) 5.35 3-7.3
Total CD4 + Tcell
counts (A + B + C)
120 293.43 (151.06) 294.5 36-859
Grouped CD4 + T cells
A (<200 cells/mm3) 36 (30%) 135.67 (37.44) 136 36-190
B (200–500 cells/mm3) 71 (59.17%) 321.27 (87.9) 312 200-500
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Figure 1 Frequency distribution of CD4 + T cell counts grouped
into intervals of 100 and plotted against the midpoint.
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Among the infectious diseases, human immunodefi-
ciency virus (HIV) infection, which eventually results
in acquired immune deficiency syndrome (AIDS), remains
a global health problem. According to the United Nations
AIDS global report [1] there are 34 million people living
with HIV globally, with 5.6 million living in South Africa.
The pathogenesis of HIV infection is considered to be
related to the depletion or reduction of CD4 + T helper
cells, causing profound immunosuppression which may
predispose the individual to aggressive gingivitis or
periodontitis unresponsive to conventional therapy [2].
Considered as one of the earliest clinical features of
HIV infection [3], many studies have related the degree
of immunosuppression and HIV viral load with the pro-
gression and exacerbation of chronic inflammatory
periodontal disease (CIPD) [4,5], with prevalence and
severity ranging from 1-66% for gingivitis and 0-91%
for periodontitis [6,7].
Periodontal disease is an inflammatory disease with a
multifactorial aetiology including immunological reac-
tions to the dental plaque or oral biofilm. With the peri-
odontium serving as a reservoir for microorganisms,
other factors such as inadequate oral hygiene, smoking,
age, and HIV stage (immunodeficiency) are recognized
as risk factors which predispose an individual to peri-
odontal disease [8-13]. Recently, the age concept has
been challenged and it is considered that with proper
oral hygiene maintenance, periodontal disease can be
prevented [14].
The literature demonstrates varying degrees of suscepti-
bility to periodontal diseases (75-80%) with 10% of the
population appearing to be completely resistant, despite
the presence of plaque [9]. It has been speculated that lack
of oral hygiene and CD4 +T cell counts <400 cells/mm3
may reduce the ability of the host to control infection by
periodontopathogens, resulting in CIPD [15-17].
The aim of the present study was to establish whether
an independent relationship exists between HIV stage
and periodontal clinical indices or whether other fac-
tors such as age, ART, smoking and/or oral hygiene
habits may govern the prevalence and severity of peri-




A cohort of 120 randomly selected male and female HIV-
positive patients attending the infectious diseases clinic at
Tygerberg Medical Hospital, South Africa participated in
the study. The study group included HIV-positive patients
aged between 17–55 years of age, regardless of their CD4 +
T cell counts or antiretroviral therapy status. Exclusion
criteria focused on pregnancy, tuberculosis, diabetes,
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tients who had received antibiotic treatment or had under-
gone dental treatment 3 months prior to the study. The
study was approved by the Research Ethical Committee
from the University of the Western Cape. All patients were
informed of the purpose of the investigation and written
consent was obtained for participation in the study. Patients
were assured of confidentiality and informed of their right
to refuse to participate or withdraw from the study. Limited
information regarding demographic features, general
health, HIV infection history, CD4 +T cell counts, smoking
and other predisposing factors to periodontal disease were
obtained from questionnaires and patients’ medical records.Measurement of periodontal indices
Periodontal clinical measurements included plaque index
(PI), gingival index (GI), probing depth (PD) and clinical
attachment loss (CAL) as previously described [18]. These
measurements were performed and recorded by a single
calibrated examiner (kappa index and intra-class coeffi-
cient correlation of agreement for PD measurements =
0.765-0.985). We elected to assess the Ramfjord teeth
which have been reported to provide a suitable alternative
for full mouth examination [19] instead of the Community
Periodontal Index of Treatment Needs (CPITN) recom-
mended by the World Health Organisation (WHO) for
epidemiological studies [20]. The reasons for this are fur-
ther defined in the discussion.Table 2 Association of clinical indices with CD4 + T cell count
Index Grouped CD4+ T cells/mm3
A (<200) n = 36 B (200-500) n = 71 C (>500) n = 13 C
PI*
Mean (SD) 2.59 (0.49) 2.52 (0.55) 2.59
Median 2.9 2.8 (0.56)
Min-Max 1.3-3.0 0.8-3.0 2.8
1.2-3.0
GI
Mean (SD) 2.8 (0.36) 2.7 (0.48) 2.7 (0.52)
Median 3.0 3.0 3.0
Min-Max 1.9-3.0 0.5-3.0 1.4-3.0
PD
Mean (SD) 4.6 (0.95) 4.83 (1.07) 4.86 (1.17)
Median 4.16 4.9 5.0
Min-Max 2.9-6.4 3.0-6.8 2.9-6.5
CAL
Mean (SD) 5.09 (1.06) 5.37 (1.07) 5.44 (1.36)
Median 5.0 5.5 5.9
Min-Max 3.0-6.9 3.3-7.3 3.0-7.0
*PI = Plaque index, GI = Gingival Index, PD = Probing depth, CAL = Clinical loss of attStatistical analysis
Data was analyzed using the SAS statistical programme
(SAS Institute Inc., Cary, NC, USA). Besides frequency
distribution, data analysis included Spearmans rank cor-
relation and Wilcoxon tests. A significance level of <0.01
indicated a highly significant result, while results with a
p-value between 0.01 and <0.05 were referred to as
significant.Results
Table 1 shows the descriptive statistics of age, CD4 + T cell
counts and periodontal indices of the 120 HIV-positive
patients included in the study. The mean age was
33.25 years with a median age of 32 years (range: 20–55).
The mean values for plaque index, gingival index, probing
depth and clinical attachment loss were 2.55, 2.75,
4.77 mm and 5.29 mm respectively.
The mean CD4 + T cell count was 293.43 cells/mm3
(Table 1). When grouped according to their CD4 + T cell
counts into groups with <200 cells/mm3 (Group A),
200–500 cells/mm3 (Group B) and >500 cells/mm3
(Group C), 30% of the patients were assigned to Group A,
indicating severe immunosuppression (Table 1), 59.17% to
Group B, a moderate degree of immunosuppression, with
Group C (11%) indicating a wide range of immune com-
petence (510–859 cells/ mm3, Table 1). Figure 1 shows the
breakdown of CD4 + T cell counts into intervals of 100,
plotted against the CD4+ midpoint.s
Levels of association
D4 + T cell Groups (A, B, C) Total CD4 + T cells (A + B + C) n = 120
rho = −0.02748 rho = 0.01514
p = 0.7657 p = 0.8696
rho = −0.03339 rho = −0.01133
p = 0.7173 p = 0.9023
rho = 0.09761 rho = 0.18472
p = 0.2889 p = 0.0434
rho = 0.12376 rho = 0.20212
p = 0.1781 p = 0.0268
achment.











Age rho 0.28149 0.18813 0.18842 0.15461
p value 0.0018 0.0396 0.0393 0.0918
HIV stage
(Groups A, B, C)
rho −0.02748 −0.03339 0.09761 0.12376
p value 0.7657 0.7173 0.2889 0.1781
Total CD4 +
T cell counts
(A + B + C)
rho 0.01514 −0.01133 0.18472 0.20212
p value 0.8696 0.9023 0.0434 0.0268
p = <0.05.
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(0.01514) and negative (−0.01133) correlations with
CD4 + T cell counts, no significant associations were
reflected in the p values, (Table 2). However, significant
correlations were indicated between clinical indices (PD,
CAL) and the total CD4+ count (A + B + C). Figure 2
demonstrates the positive Spearman’s correlation be-
tween clinical attachment level and CD4 + T cell counts.
The lack of a correlation between individual groups A, B
and C, with any of the clinical indices (Table 2), shows
that the prevalence of periodontal disease in HIV-positive
patients may not directly be related to the different stages
of immunosuppression even though total CD4+ counts
could be associated with changes observed in the peri-
odontal measurements.Influence of age on clinical indices
With an age range of 20–55 years (Table 1), we used
Spearman rank correlation to examine whether age in-
fluenced the measurement of periodontal indices. Age
was related to the clinical indices regardless of the pa-
tients’ CD4 + T cell counts or their stages of immuno-
suppression. A highly significant positive correlation was
found between age and plaque index (p = 0.0018) with a
significant correlation with gingival index and probing
depth (Table 3). However the level of clinical attachment
showed no significant correlation with age.Influence of HIV stage on clinical indices
Significant associations were observed between total CD4 +
T cell counts (A + B +C) and probing depth (p = 0.0434)
and between total CD4+ T cell counts and clinical attach-
ment loss (p = 0.0268), but when the counts were grouped
according to HIV stage (A, B and C), these associations
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Figure 2 Correlation of CD4 + T cell counts with clinical
attachment level.Influence of smoking on clinical indices
A noticeable but not significant difference was observed
between smokers and non-smokers for total CD4+
counts (Table 4) but not for HIV stage (data not shown),
although significant differences were observed between
smokers and non-smokers for all of the clinical indices,
with the exception of the gingival index (Table 4).
Association between HIV stage and anti-retroviral therapy
(ART)
A greater percentage of HIV patients on ART belonged
to Group B, while many of the Group A patients were
not on ART (Table 5). Pearson’s chi-square test indicated
a highly significant difference between HIV stage and
ART (Table 5).
Influence of ART on clinical indices
The median for CD4+ T cell counts of patients on ART
was higher than for those not on ART, with a highly sig-
nificant positive relationship found between total CD4 +
T cell counts and ART (Table 6). ART significantly influ-
enced probing depth (p = 0.0065) and clinical attachment
level (p = 0.0029), while no significant relationships were
found between ART and plaque index, nor between ART
and gingival index.
Influence of oral health care on clinical indices
When questioned about frequency of visits to the den-
tist, 19% of the cohort reported never seeing the dentist,
52% said they saw a dentist once in 5 years and the re-
mainder (29%) claimed they had visited the dentist 2 or
more times in the past 5 years.
The majority (70%) reported brushing once a day, while
only 30% brushed twice a day. Only 26% reported using
interdental aids. A significant difference (p = 0.0352) was
observed for plaque index scores of patients who brushed
twice a day compared with those who brushed once a day.
None of the other clinical indices showed any correlation
with frequency of brushing (Table 7). With the exception
of probing depth, all the clinical indices were significantly
Table 4 Influence of smoking on CD4+ counts and clinical indices
Smoking
Yes (n = 60) No (n = 60)
Variables Mean (SD) Median Minimum-Maximum Mean (SD) Median Minimum-Maximum p value
CD4 + T cell counts 322.45 (164.46) 312 61-859 264.4 (131.4) 214 36-562 0.0540
Plaque index 2.66 (0.49) 2.9 0.8-3 2.44 (0.56) 2.55 1.2-3 0.0180
Gingival index 2.8 (0.45) 3 0.5-3 2.70 (0.45) 3 1.4-3 0.1500
Probing depth 4.99 (0.9) 5 3-6.8 4.54 (1.04) 4.15 2.9-6.4 0.0191
Clinical attachment level 5.55 (1) 5.75 3.4-7.3 5.03 (1.13) 5 3-7.1 0.0109
(p < 0.05).
Table 5 HIV stage relative to ART
ART Grouped CD4 + T cell counts (A,B,C)
(p = <0.0001)
Total
A (<200) B (200–500) C (>500)
Negative 32 (68.1%) 14 (29.8%) 1 (2.2%) 47 (39.2%)
Positive 4 (5.5%) 57 (78.1%) 12 (16.5%) 73 (60.9%)
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association of clinical indices with CD4+ counts was also
significantly improved with adequate oral hygiene prac-
tices (Table 7).
Discussion
HIV-AIDS is characterised by a profound immunodefi-
ciency resulting from the depletion of CD4+ T helper
lymphocytes. Thus CD4+ cell counts are used to stage
HIV-AIDS and to initiate antiretroviral therapy [17].
Earlier studies report that 90% of HIV-positive individ-
uals present with oral manifestations of disease [15] in-
cluding necrotizing ulcerative gingivitis and periodontitis
[21]. There is however, no consensus on the association of
HIV with periodontal status [22-24]. The issue appears to
be clouded by confounding factors such as the level of im-
munosuppression (HIV stage) and other risk factors for
HIV-associated periodontitis [25]. Community periodontal
index of treatment needs (CPITN) scores were not used in
this study, since previous studies considered it to overesti-
mate the prevalence and severity of periodontal attachment
loss among younger individuals, while underestimating
them in the elderly [26,27]. In CPITN or CPI (Community
Periodontal Index), the mouth is divided into sextants and
index or all teeth are examined for the presence or absence
of periodontal pockets, calculus and gingival bleeding and
the highest score for each sextant noted. Although easy to
use and therefore frequently used in epidemiological stud-
ies [28], limitations include the lack of measurement of
tooth mobility and attachment loss [29,30] , which, along
with probing pocket depth, are considered by most epide-
miologists as being good indicators of periodontal disease.
In addition, CPITN also assumes that a correlation exists
between the presence of calculus and periodontal inflam-
mation; an assumption which has been questioned [26,27].
The epidemiological validity of the Ramfjord teeth in
representing the periodontal status of the whole mouth has
previously been established [23-28]. Although we are
mindful of the limitations of partial mouth measurements
such as the underestimation of both the extent and preva-
lence of periodontal disease reported in some studies
[27,31] and the bias reported in others [29,30,32], withmeasurement of sites on the buccal side of the tooth re-
ported to show better reliability than measurement on the
lingual side because of better visibility to the examiner, as-
sessment of the Ramfjord teeth was found to reduce time,
cost, patient, and examiner fatigue, while also providing a
practical alternative to the 168 measurements for each
clinical parameter required to characterise the prevalence
and severity of periodontal disease in a single whole mouth
using full mouth assessment [27].
This is one of very few studies which have attempted
to associate HIV stage with periodontal indices, particu-
larly in developing countries. A study by Vastardis et al.
[25] examined for an association of periodontal indices
with stages of HIV infection. They determined that for
individuals with moderate or severe immunosuppression
(CD4 + T cell count <500 cells/mm3), a significant posi-
tive correlation existed with modified gingival index and
bleeding index, with no significant correlation with clin-
ical attachment level (p = 0.0560). Unlike the present
study, they, along with other researchers [24] could not
find any significant association between periodontal indi-
ces and CD4 + T cell counts for all the individuals exam-
ined. Moreover only 39 patients were used in their study
compared to the present study with a sample size of
120. Robinson et al. [32] also reported an association of
clinical attachment destruction with progressive HIV in-
fection but not with probing depth. It is generally ex-
pected that the lower the immunosuppression of an
individual, the higher the severity of periodontal dis-
ease detected [21]. In the present investigation, pa-
tients were divided into three groups on the basis of
their HIV stage as depicted by their CD4+ counts,
namely, A (<200 cells/ mm3), B (200-500 cells/mm3)
and C (>500 cells/mm3). Although moderate to severe
Table 6 CD4+ T cell counts and clinical indices relative to ART
ART
Yes (N = 73) No (N = 47)
Variables Mean (SD) Median Min-Max Mean (SD) Median Min-Max Spearmans correlation (p value)
CD4 + T cell counts 377.74 (126.97) 352 140-859 162.47 (70.67) 158 36-520 0.77004 (<.001)
Plaque index 2.58 (0.53) 2.8 0.8-3 2.51 (0.55) 2.8 1.3-3 0.03499 (0.7044)
Gingival index 2.75 (0.48) 3 0.5-3 2.76 (0.4) 3 1.8-3 −0.01551 (0.8665)
Probing depth 4.97 (1) 5 2.9-6.8 4.45 (1) 4 2.9-6.4 0.24716 (0.0065)
Clinical attachment 5.53 (1.03) 5.6 3-7.3 4.92 (1) 4.6 3-6.9 0.26956 (0.0029)
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majority of individuals presenting with probing depths
and clinical attachment levels > 5 mm, no significant
associations were found between any of the periodontal
indices and HIV stage. However, when examining the en-
tire HIV + cohort, significant associations were observed
between CD4+ counts and probing depth (p = 0.0434) and
CD4+ counts and clinical attachment level (p = 0.0268). A
relationship existed between the immunosuppression of
the study group and their periodontal status, but the level
of immunosuppression did not appear to favour the se-
verity of periodontal disease. These findings are similar
to those of other researchers who found periodontal
disease to be less prevalent in subjects with CD4+
counts < 200 cells/mm3 than in subjects with CD4+
counts > 500 cells/mm3 [26,32-35]. They observed lin-
ear gingival erythema (LGE) and necrotizing ulcerativeTable 7 Clinical indices relative to oral health care and CD4 c
Oral care Plaque index Gingival
Brushing frequency
once a day Mean (SD) 2.63 (0.4) 2.79 (
n = 84 Median 2.9 3.0
Minimum-maximum 1.2-3.0 1.4-3
twice a day Mean (SD) 2.38 (0.58) 2.67 (0
n = 36 Median 2.4 2.9
Minimum-maximum 0.8-3.0 0.5-3
Significance p = 0.0352 0.09
Use of interdental aids
Mean (SD) 2.279 (0.6) 2.57 (0
Yes Median 2.2 2.8
n = 26 Minimum-maximum 0.8-3.0 0.5-3
No Mean (SD) 2.63 (0.49) 2.8 (0
n = 94 Median 2.9 3.0
Minimum-maximum 1.2-3.0 1.4-3
Significance p = 0.0110 0.01
p = <0.05.gingivitis (NUG) in patients comparable to our group B
only but not the A nor C groups. They also reported
that necrotizing ulcerative periodontitis (NUP) oc-
curred with similar prevalence in groups A and B, but
not in C. These studies support the suggestion that the
use of antiretroviral therapy (ART) has modified the
prevalence and course of periodontal disease in HIV-
positive patients [12,13,35,36] with reduced incidence
of periodontal damage [37-39].
Other confounding factors such as age, smoking and
oral hygiene practices were also investigated in the
present study. There were significant positive relation-
ships found between gingival index (p = 0.0396) and
probing depth (p = 0.0393) with the age of the study
population. Plaque index also showed a highly significant
(p = 0.0018) positive relationship with age. The age range
of the study population (20–55 years) may support theounts (Wilcoxon test)
index Probing depth Clinical attachment loss CD4 + T counts
0.4) 4.86 (1.0) 5.39 (1.1) 313.14 (152.63)
5.0 5.6 312
.0 2.9-6.8 3.0-7.3 61-859
.53) 4.55 (1.0) 5.06 (1.0) 247.45 (138.7)
4.15 5.0 213
.0 3.0-6.8 3.3-7.0 36-700
11 0.1376 0.1101 0.0190
.59) 4.45 (1.17) 4.89 (1.12) 231.35 (142.28)
5 4.0 4.6 211.5
.0 3.0-6.5 3.3-6.9 36-700
.39) 4.86 (0.99) 5.3 (1.07) 310.6 (149.6)
5.0 5.6 308
.0 2.9-6.8 3.0-7.3 90-859
02 0.0762 0.0336 0.0170
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ing periodontal disease are increased [16]. A study by
Yalcin et al. [40] reported no association between clinical
parameters and age.
Smoking showed a marked although not significant as-
sociation with CD4+ cell counts (p = 0.0540), while being
significantly related to plaque index, probing depth and
clinical attachment loss. Hence, the present study con-
firmed smoking as a major risk factor for periodontal
disease as found in previous studies [41-43] and highlighted
the advantage of smoking cessation in improving the oral
health and quality of life of HIV-positive patients [44-46].
It is generally accepted that good oral hygiene is essen-
tial in maintaining a disease-free mouth. The present
study included patients who had not received dental
treatment 3 months prior to the study, thus increasing
their chances of developing periodontal disease. When
the periodontal clinical indices were related to the oral
hygiene practices, the frequency of brushing was
found to be significantly associated with plaque index
(p = 0.0352) but not with the other periodontal indices.
However, the use of interdental aids showed signifi-
cant associations with all of the periodontal indices
except the probing depth. These results clearly suggest
that although increased frequency of brushing may
have reduced the initial plaque accumulation, the add-
itional use of interdental aids provided better plaque
control and improved gingival health. Moreover, only
10.83% of the individuals managed regular dental
visits. This may be due to a host of factors including a
general lack of interest for maintaining better oral hy-
giene, lack of access to medical and dental care or
other factors beyond their control.
A significant association was established between HIV
stage and brushing frequency (p = 0.0190) as well as the
use of interdental aids (p = 0.0170). These results reveal
that the clinical signs and symptoms of gingival and
periodontal disease with reduced CD4 + T cell counts
remain a significant complication of HIV infection.
In selecting the study group, no consideration was
given to whether patients were on antiretroviral therapy
or not, since no consistency of the effect of ART on
periodontal disease progression has ever been demon-
strated [47]. Because different stages of HIV were being
compared, it was considered outside of the scope of this
study to include a healthy HIV-negative control group.
A direct comparison of this to other studies was compli-
cated by the lack of data reported, including the use and
duration of antiretroviral therapy and adjunctive antimi-
crobials, the broad reference in the literature to HIV-
positive subjects without referring to their HIV stage,
and the lack of mention of confounding factors such as
age, smoking, oral hygiene and other risk factors for
periodontal diseases.Conclusion
This study established an association between CD4 +
T cell counts and chronic inflammatory periodontal
disease in HIV-positive patients regardless of their
HIV stage. The high prevalence of periodontal mani-
festations underlines the need for proper home care,
appropriate periodontal treatment and maintenance to
provide reasonably good periodontal health among
HIV-positive individuals. Although ART significantly
influenced PD and attachment levels in these HIV-
positive patients, the findings of this study conclude
that their susceptibility to disease is largely deter-
mined by their oral hygiene and smoking habits rather
than age, ART or HIV stage.
Abbreviations
AIDS: Acquired immune deficiency syndrome; ART: Anti-retroviral therapy;
CD4+ T cells: Cluster of Differentiation 4 T Helper Lymphocytes;
CIPD: Chronic inflammatory periodontal disease; CPITN: Community
periodontal index of treatment needs; HIV: Human immunodeficiency virus;
LGE: Linear gingival erythema; NUG: Necrotising ulcerative gingivitis;
NUP: Necrotising ulcerative periodontitis.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CNJ carried out the clinical study, collected the data for analysis and drafted
the manuscript. LXGS participated in the design of the study and supervised
the clinical work. CWJA contributed to the conceptual design, interpretation
of data, funding of the project, writing of the manuscript. All authors read
and approved the final manuscript.
Authors’ information
CNJ: Recently completed the degree MSc Oral Medicine and Periodontology
at the University of the Western Cape and accepted a position at a
University in Oman. LXGS (PhD, BChD) is Professor and Head of the
Department of Oral Medicine and Periodontology in the Faculty of Dentistry
at the University of the Western Cape. CWJA (PhD Med., MSc Dent) is
Professor and Head of the Medical Microbiology Cluster in the Department
of Medical Biosciences, University of the Western Cape.
Acknowledgements
This material is based upon work supported financially by the National
Research Foundation (NRF). The authors wish to thank all our subjects who
volunteered to participate in this study, the staff at the infectious disease
clinic for their assistance in recruiting the patients, as well as Prof. Richard
Madsen for statistical assistance.
Disclaimer
Any opinion, findings and conclusions or recommendations expressed in this
material are those of the authors and therefore the NRF does not accept any
liability in regards thereto.
Author details
1Department of Periodontics and Oral Medicine, University of the Western
Cape, Western Cape, South Africa. 2Anaerobe group, Department of Medical
Biosciences, University of the Western Cape, Western Cape, South Africa.
Received: 16 July 2013 Accepted: 26 November 2013
Published: 3 December 2013
References
1. UNAIDS: UNAIDS report on the global AIDS epidemic 2013. Available: http://
www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/
2013/gr2013/UNAIDS_Global_Report_2013_en.pdf. UNAIDS, Geneva,
Switzerland. [Accessed 28 November 2013].
John et al. BMC Oral Health 2013, 13:69 Page 8 of 8
http://www.biomedcentral.com/1472-6831/13/692. Winkler JR, Robertson PB: Periodontal disease associated with HIV
infection. Oral surgery, oral medicine, and oral pathology 1992,
73(2):145–150.
3. Robinson PG: The significance and management of periodontal lesions in
HIV infection. Oral diseases 2002, 8(Suppl 2):91–97.
4. Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, Kingsley
LA, Todd JA, Saah AJ, Detels R, et al: Plasma viral load and CD4+
lymphocytes as prognostic markers of HIV-1 infection. Annals of internal
medicine 1997, 126(12):946–954.
5. Kinane DF: Periodontitis modified by systemic factors. Annals of
periodontology / the American Academy of Periodontology 1999, 4(1):54–64.
6. Ranganathan K, Reddy BV, Kumarasamy N, Solomon S, Viswanathan R,
Johnson NW: Oral lesions and conditions associated with human
immunodeficiency virus infection in 300 south Indian patients.
Oral diseases 2000, 6(3):152–157.
7. Eyeson JD, Warnakulasuriya KA, Johnson NW: Prevalence and incidence of
oral lesions–the changing scene. Oral diseases 2000, 6(5):267–273.
8. Umeda M, Chen C, Bakker I, Contreras A, Morrison JL, Slots J: Risk indicators
for harboring periodontal pathogens. Journal of periodontology 1998,
69(10):1111–1118.
9. Tucker R: Periodontitis and pregnancy. The journal of the Royal Society for
the Promotion of Health 2006, 126(1):24–27.
10. Loesche WJ, Grossman NS: Periodontal disease as a specific, albeit
chronic, infection: diagnosis and treatment. Clinical microbiology reviews
2001, 14(4):727–752. table of contents.
11. Patton LL: Sensitivity, specificity, and positive predictive value of oral
opportunistic infections in adults with HIV/AIDS as markers of immune
suppression and viral burden. Oral surgery, oral medicine, oral pathology,
oral radiology, and endodontics 2000, 90(2):182–188.
12. Schmidt-Westhausen AM, Priepke F, Bergmann FJ, Reichart PA: Decline in
the rate of oral opportunistic infections following introduction of highly
active antiretroviral therapy. Journal of oral pathology & medicine: official
publication of the International Association of Oral Pathologists and the
American Academy of Oral Pathology 2000, 29(7):336–341.
13. Gaitan Cepeda LA, Ceballos Salobrena A, Lopez Ortega K, Arzate Mora N,
Jimenez Soriano Y: Medicina oral, patologia oral y cirugia bucal 2008,
13(2):E85–E93.
14. Lindhe J: Epidemiology of periodontal disease. In Clinical Periodontology
and Implant dentistry, Volume 7. 5th edition. 2008:129–155.
15. Murray PA: HIV disease as a risk factor for periodontal disease. Compend
Contin Ed Dent 1994, 15:1052–1064.
16. Barr C, Lopez MR, Rua-Dobles A: Periodontal changes by HIV serostatus in a
cohort of homosexual and bisexual men. Journal of clinical periodontology
1992, 19(10):794–801.
17. Lewis DA: Antiretroviral combination therapy for HIV infection. Dental
update 2003, 30(5):242–247.
18. John CN, Stephen LXG, Africa CWJ: BANA-Positive Plaque Samples Are
Associated with Oral Hygiene Practices and Not CD4+ T Cell Counts in
HIV-Positive Patients. International journal of dentistry 2012, 2012:157641.
19. Dowsett SA, Archila L, Segreto VA, Eckert GJ, Kowolik MJ: Periodontal
disease status of an indigenous population of Guatemala, Central
America. Journal of clinical periodontology 2001, 28(7):663–671.
20. Barmes D: CPITN–a WHO initiative. International dental journal 1994,
44(5 Suppl 1):523–525.
21. Rozra S, Kundu D, Saha B, Rudra A, Chakrabarty S, Bharati P: Periodontal
status of HIV-infected patients with special reference to CD4 cell count
in Western Bengal. India. Asian Pacific J Tropical Disease 2012, 2(6):470–474.
22. Fricke U, Geurtsen W, Staufenbiel I, Rahman A: Periodontal status of HIV-
infected patients undergoing antiretroviral therapy compared to HIV-
therapy naive patients: a case control study. European journal of medical
research 2012, 17:2.
23. Stojkovic A, Boras VV, Planbak D, Lisic M, Srdjak S: Evaluation of periodontal
status in HIV infected persons in Croatia. Collegium antropologicum 2011,
35(1):67–71.
24. Phiri R, Feller L, Blignaut E: The severity, extent and recurrence of
necrotizing periodontal disease in relation to HIV status and CD4+ T cell
count. J Int Acad Periodontol 2010, 12(4):98–103.
25. Vastardis SA, Yukna RA, Fidel PL Jr, Leigh JE, Mercante DE: Periodontal disease
in HIV-positive individuals: association of periodontal indices with stages of
HIV disease. Journal of periodontology 2003, 74(9):1336–1341.26. Holmgren CJ, Corbet EF: Relationship between periodontal parameters
and CPITN scores. Community dentistry and oral epidemiology 1990,
18(6):322–323.
27. Leroy R, Eaton KA, Savage A: Methodological issues in epidemiological
studies of periodontitis–how can it be improved? BMC oral health 2010, 10:8.
28. Benigeri M, Brodeur JM, Payette M, Charbonneau A, Ismail AI: Community
periodontal index of treatment needs and prevalence of periodontal
conditions. Journal of clinical periodontology 2000, 27(5):308–312.
29. Baelum V, Fejerskov O, Manji F: Periodontal diseases in adult Kenyans.
Journal of clinical periodontology 1988, 15(7):445–452.
30. Cutress TW, Ainamo J, Sardo-Infirri J: The community periodontal index of
treatment needs (CPITN) procedure for population groups and individuals.
International dental journal 1987, 37(4):222–233.
31. McKaig RG, Patton LL, Thomas JC, Strauss RP, Slade GD, Beck JD: Factors
associated with periodontitis in an HIV-infected southeast USA study.
Oral diseases 2000, 6(3):158–165.
32. Robinson PG, Sheiham A, Challacombe SJ, Zakrzewska JM: The periodontal
health of homosexual men with HIV infection: a controlled study.
Oral diseases 1996, 2(1):45–52.
33. Induchoodan A: Periodontal status in stages of HIV disease - A short-
term clinical study. Perio 2008, 5(4):247–250.
34. Sontakke SA, Umarji HR, Karjodkar F: Comparison of oral manifestations
with CD4 count in HIV-infected patients. Indian journal of dental research:
official publication of Indian Society for Dental Research 2011, 22(5):732.
35. Mataftsi M, Skoura L, Sakellari D: HIV infection and periodontal diseases:
an overview of the post-HAART era. Oral diseases 2011, 17(1):13–25.
36. Patton LL, McKaig R, Strauss R, Rogers D, Eron JJ Jr: Changing prevalence
of oral manifestations of human immuno-deficiency virus in the era of
protease inhibitor therapy. Oral surgery, oral medicine, oral pathology, oral
radiology, and endodontics 2000, 89(3):299–304.
37. Mulligan R, Phelan JA, Brunelle J, Redford M, Pogoda JM, Nelson E, Seirawan
H, Greenspan JS, Navazesh M, Greenspan D, et al: Baseline characteristics
of participants in the oral health component of the Women’s
Interagency HIV Study. Community dentistry and oral epidemiology 2004,
32(2):86–98.
38. Greenspan D, Gange SJ, Phelan JA, Navazesh M, Alves ME, MacPhail LA,
Mulligan R, Greenspan JS: Incidence of oral lesions in HIV-1-infected
women: reduction with HAART. Journal of dental research 2004,
83(2):145–150.
39. Bloom B, Adams PF, Cohen RA, Simile C: Smoking and oral health in
dentate adults aged 18–64. NCHS data brief 2012, 85:1–8.
40. Yalcin F, Eskinazi E, Soydinc M, Basegmez C, Issever H, Isik G, Berber L, Has R,
Sabuncu H, Onan U: The effect of sociocultural status on periodontal
conditions in pregnancy. Journal of periodontology 2002, 73(2):178–182.
41. Bergstrom J, Preber H: Tobacco use as a risk factor. Journal of
periodontology 1994, 65(5 Suppl):545–550.
42. Albandar JM, Streckfus CF, Adesanya MR, Winn DM: Cigar, pipe, and
cigarette smoking as risk factors for periodontal disease and tooth loss.
Journal of periodontology 2000, 71(12):1874–1881.
43. Calsina G, Ramon JM, Echeverria JJ: Effects of smoking on periodontal
tissues. Journal of clinical periodontology 2002, 29(8):771–776.
44. VanDevanter N, Dorsen CG, Messeri P, Shelley D, Person A: Oral health care
and smoking cessation practices of interprofessional home care
providers for their patients with HIV. Journal of interprofessional care 2012,
26(4):339–340.
45. Jeganathan S, Batterham M, Begley K, Purnomo J, Houtzager L: Predictors
of oral health quality of life in HIV-1 infected patients attending routine
care in Australia. Journal of public health dentistry 2011, 71(3):248–251.
46. Tomar SL, Pereyra M, Metsch LR: Oral health-related quality of life among
low-income adults living with HIV. J of public health dentistry 2011,
71(3):241–247.
47. Alves M, Mulligan R, Passaro D, Gawell S, Navazesh M, Phelan J, Greenspan
D, Greenspan JS: Longitudinal evaluation of loss of attachment in HIV-
infected women compared to HIV-uninfected women. J of periodontology
2006, 77(5):773–779.
doi:10.1186/1472-6831-13-69
Cite this article as: John et al.: Is human immunodeficiency virus (HIV)
stage an independent risk factor for altering the periodontal status of
HIV-positive patients? A South African study. BMC Oral Health 2013 13:69.
